Navigation Links
United Kingdom Is Lagging In Novelty In The Field Of Pharmaceuticals

United Kingdom is lagging in innovation, as shown by the market share of new medicines in various countries, including primary care and hospital markets. Reports from various sources prove that Europe has shown very low growth in the field of pharmaceuticals and hospital care//.

Europe has a new plan in order to counter the worsening competitive position of its biopharmaceutical enterprises. The policy is nominally based on a report submitted by Boston based international consultancy Charles River Associates (CRA) to the European Commission to investigate the status and reasons for Europe’s decline in Pharma industry.

Although the US market experienced similar landslides it has been able to grow to higher proportion in the field of new biologics. This is not happening in the case of Europe. “The decline is real and is likely to get worse,” noted independent biotech consultant David Glover, former research director of Cambridge Antibody Technology. Many young European firms, he said, are becoming disillusioned with the lack of reward for innovation.

European Commission Vice president Gunter Verheugen has announced a policy for referendum of the Europe’s biotech policy. The first aspect would be to double the financial support for life sciences research, taken from the six year, $132 billion Research Framework program that begins in 2007. The second aspect would be greasing the wheels of safety and efficacy testing for new types of medicines. The third policy would be to resolving a patchwork of different national systems for drug pricing, which” place a significant burden on industry and can delay access to the market.” The last policy of restricting on patients access to information on new medicines are to be considered.

Verheugen is confident that the program will deliver some concrete results within three years.

Source: Nature Biotechnoogy
'"/>




Page: 1

Related medicine news :

1. Scientists plan human cloning clinic in the United States
2. GlaxoSmithKline to Supply United States with 8 Million flu vaccine, Fluarix
3. United Kingdom to perform its first Live Liver Transplant
4. Inhospitable Response Curtail Growth Of Specialty Hospitals: United States
5. United Kingdom: Farmers Cautioned To Plan Adequately For Bird-Flu
6. Bird-Flu Causes Alarm in United Kingdom.
7. 2010 AIDS Target May Misfire, Warns United Nations
8. AIDS Meet Ends Without Firm Commitments From Donors Dharam Shourie United Nations
9. United Nations draws flak Due to Lukewarm AIDS Prevention Measures
10. Chinese Poultry Smuggled into United States
11. United Kingdom: Making the most of sunshine without the cream
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/8/2016)... ... , ... Discover the Rocky Mountain region’s longest running and impressive garden and ... also get to see the most incredible gardens and home improvement experts that attend ... Colorado Convention Center - 700 14th St. Denver CO, is an exciting event that ...
(Date:2/8/2016)... Nevada (PRWEB) , ... February 08, 2016 , ... ... RowdMap, Inc., will be speaking on how healthcare companies can use newly released ... manage the health of a population and intervene and capture the value they ...
(Date:2/7/2016)... , ... February 07, 2016 , ... ... with the latest techniques and the most minimally invasive approaches. , Women who ... particularly after menopause. Other risk factors include surgery to the pelvic floor, connective ...
(Date:2/6/2016)... ... February 06, 2016 , ... ... NURSES EXPECTED AT AORN SURGICAL CONFERENCE & EXPO , WHAT:     , This ... an estimated 5000 perioperative nurses in attendance to study the latest evidence-based ...
(Date:2/6/2016)... ... February 06, 2016 , ... Research has shown ... to reduce the frequency and level of relapse. , At the ... and Purpose,” will explore the critical tasks of the recovery phase and beyond ...
Breaking Medicine News(10 mins):
(Date:2/8/2016)... Feb. 8, 2016 Velano Vascular, a medical ... hospitalized patients and their practitioners, announced today that the ... Velano will use the proceeds from this financing, an ... in January 2015, to support the development and commercialization ... pediatric populations. Philadelphia , ...
(Date:2/8/2016)... CARLSBAD, Calif. , Feb. 8, 2016  HemaFlo Therapeutics, ... Office (USPTO) has issued US Patent Number 9,119,880 covering the ... Dale Peterson , PhD, HemaFlo,s founder, said, "We ... technology." --> Dale Peterson , PhD, HemaFlo,s ... such a powerful technology." --> Dale ...
(Date:2/8/2016)... , Feb. 8, 2016  Astellas Pharma Inc. President and ... promotion of James Robinson as president, Americas Operations, ... in North and South America , effective ... US, representing the commercial organization in the United ... Masao Yoshida , who is retiring in ...
Breaking Medicine Technology: